These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6983693)
1. Leukemia-derived growth factor (non-interleukin 2) produced by a human malignant T lymphoid cell line. Uittenbogaart CH; Fahey JL Proc Natl Acad Sci U S A; 1982 Nov; 79(22):7004-8. PubMed ID: 6983693 [TBL] [Abstract][Full Text] [Related]
2. Leukemia-derived growth factor (non-interleukin-2) produced by murine lymphoma T-cell lines. Hays EF; Goodrum D; Bessho M; Kitada S; Uittenbogaart CH Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7807-11. PubMed ID: 6595661 [TBL] [Abstract][Full Text] [Related]
3. Leukemia derived growth factors produced by human malignant T-lymphoid cell lines. Uittenbogaart CH; Nishanian PG; Anisman DJ; Erikson TK; Fahey JL Cancer Res; 1986 Mar; 46(3):1219-23. PubMed ID: 3080240 [TBL] [Abstract][Full Text] [Related]
4. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Fernandez-Pol JA; Klos DJ; Grant GA Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
6. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979 [TBL] [Abstract][Full Text] [Related]
7. Constitutive production of B cell differentiation factor-like activity by human T and B cell lines. Kanowith-Klein S; Saxon A; Uittenbogaart CH Eur J Immunol; 1987 May; 17(5):593-8. PubMed ID: 3495441 [TBL] [Abstract][Full Text] [Related]
8. Growth of human malignant lymphoid cell lines in serum-free medium. Uittenbogaart CH; Cantor Y; Fahey JL In Vitro; 1983 Jan; 19(1):67-72. PubMed ID: 6600440 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a leukemia-derived transforming growth factor. Zack J; Smith RG; Ozanne B Leukemia; 1987 Nov; 1(11):737-45. PubMed ID: 3500371 [TBL] [Abstract][Full Text] [Related]
11. Autocrine growth of murine lymphoma cells. Hays EF; Kitada S; Uittenbogaart CH; Reeve JR J Natl Cancer Inst; 1988 Mar; 80(2):116-21. PubMed ID: 3343687 [TBL] [Abstract][Full Text] [Related]
12. Deoxynucleotide-polymerizing enzyme activities in T- and B-cells of acute lymphoblastic leukemia origin. Srivastava BI Cancer Res; 1976 May; 36(5):1825-30. PubMed ID: 1083765 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth. Valtieri M; Santoli D; Caracciolo D; Kreider BL; Altmann SW; Tweardy DJ; Gemperlein I; Mavilio F; Lange B; Rovera G J Immunol; 1987 Jun; 138(11):4042-50. PubMed ID: 2953797 [TBL] [Abstract][Full Text] [Related]
14. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines. Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237 [TBL] [Abstract][Full Text] [Related]
15. Rosette-forming human lymphoid cell line (T-cell line molt). II. Ability for clonal growth. Itoh U; Minowada J; Moore GE; Pressman D J Natl Cancer Inst; 1974 May; 52(5):1403-7. PubMed ID: 4545482 [No Abstract] [Full Text] [Related]